| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001962 | American Journal of Ophthalmology | 2015 | 11 Pages |
Abstract
This study showed that although transepithelial CXL was a safe procedure without epithelial healing problems, 23% of cases showed a continued keratoconus progression after 1 year. Therefore, at this time, we do not recommend replacing epi-off CXL by transepithelial CXL for treatment of progressive keratoconus.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Nienke Soeters, Robert P.L. Wisse, Daniël A. Godefrooij, Saskia M. Imhof, Nayyirih G. Tahzib,